Navigation Links
Pinpointing cause of colic: UT Houston researchers identify organism
Date:7/24/2009

r and lasts for more than three hours daily for at least three days a week."Colic is a very common condition. It affects about 15 percent of normal, healthy infants. More than half of infanticides fall into the age category of colic. We may be able to prevent deaths if we can find a treatment," Rhoads said.

Right now, pediatricians prescribe special hypoallergenic infant formula to try and treat colic, but none of it has been proven in studies to be effective in treating the condition.

"During our study, we also found that the babies that didn't have colic had more types of bacteria in their intestines. The presence of more bacteria may indicate that specific bacterial species (phylotypes) are beneficial to humans," Rhoads said.

The study was funded by the Gerber Foundation.

A larger study is needed to examine Klebsiella and the use of a probiotic, which is a dietary supplement made up of good bacteria, to control the gut inflammation. Before that can begin, Rhoads said an adult trial will take place to examine the safety of the probiotics in healthy adults. For that study, UT researchers are recruiting 40 adult patients.


'/>"/>

Contact: Melissa McDonald
Melissa.E.McDonald@uth.tmc.edu
713-500-3308
University of Texas Health Science Center at Houston
Source:Eurekalert

Page: 1 2

Related medicine news :

1. VIDEO from Medialink and Siemens: Pinpointing Prostate Cancer in Larger Patients
2. NIH Plan Charts Course to Better Treatments and Cure for Most Common Known Genetic Cause of Autism: Fragile X
3. Large abdominal wall lipoma causes bowel obstruction
4. Fitness Gurus Warn Women Not To Give Up On Their Diet Just Because Summer Has Arrived
5. Was SIDS the cause of infant deaths even 150 years ago?
6. Drug Crimes in Canada Cause Continuing Problems for Small Communities
7. Catastrophic Epilepsy Caused by Defect in One Gene
8. NIA Says Health Care Will Cause U.S. Dollar Collapse
9. Mini-Strokes May Cause Vision Loss
10. Statins May Cause Muscle Damage in Some Patients
11. CU-Boulder study shows brains immune system may cause chronic seizures

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...c.todayannouncedtheacquisitionofRetirementCapitalG...sationandbenefitplanprovidersheadquarteredinSanDie...waukee,Boston,ChicagoandAtlanta.RCGwasfoundedin200...enefitsindustry. ,, "Weareexcitedtoannouncethea...sence,"statesBillPollock,ChairmanandFounderofNIP."...
(Date:11/24/2009)...re/--Dr.NelsonEscobar,aphysicianwiththeMarianjoyMe...Award.TheawardwaspresentedtohimbytheBrainInjuryAss...onOctober30,2009. ,, AccordingtotheBIAofIllinoi...rtiseinaddressingthecomplexneedsofpersonswithbrain...reofhispatientsandtheirfamiliesastheyrebuildtheirl...
(Date:11/24/2009)...CenteneCorporation(NYSE: CNC )todayannouncedthatth...oneoftwoCoordinatedCareOrganizationstoparticipatei...iCAN),acoordinatedcareprogramforMississippiMedicai...ecuteacontractinwhichthecompanywillserveeligibleme...lia). ,, BasedinJackson,Miss.,Magnoliawillworkw...
(Date:11/24/2009)...etween high- and low-volume centers, study found ,...Do hospitals that conduct the most angioplasties n...Maybe not. , Prior research had suggested that ...pening procedures, but a new study involving over ...ls performing more or less equally. , The study...
(Date:11/24/2009)... use but higher costs , , TUESDAY, Nov. ... may contribute to higher Medicaid costs, accordin... used antiplatelet drug clopidogrel (Plavix). ,...te Medicaid programs found that direct-to-consumer...le,s use of the drug but appeared to be associated...
Breaking Medicine News(10 mins):Health News:NIP Acquires San Diego Executive Benefits Firm 2Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Advertising to Consumers May Raise Drug Prices 2
..., Feb. 12 Affirming its commitment,to preventing ...onal,Lieutenant Governors Association Executive Co...n John R. Elliott HERO Campaign for Designated Dri...ng.,It was established by the family of Navy Ensig...
... MONICA, Calif., Feb. 12 A consumer,group today r...nathan,Gruber supporting mandatory purchase of pri... that most Americans are "over-insured" and to,def...rwatchdog.org/resources/MandatoryInsuranceCritique...
...ing quickly mutating noroviruses might mean yearly...HealthDay News) -- It may be possible to develop a...of stomach flu -- but it,s likely a such a vaccine...nfect cells after attaching to histo-blood group a...
...Feb. 12 PSI, a leading provider of child,support ...nced today the,signing of a contract with the Ohio...continue delivering new hire reporting services fo...r extensions., Key responsibilities under the con...
...oard aimed at reducing cross contaminations includ... MRSA, JACKSONVILLE, Fla., Feb. 12 Seal Shield L...LVER SEAL(TM) Washable, Antimicrobial,Keyboard. Ac...from SILVER SEAL(TM) Antimicrobial plastic. The SI...
...ON, Fla., Feb. 12 The Generic Pharmaceutical,Asso...members of its newly,elected Executive Committee a...nt and CEO of Teva North America, to serve as its ... top 20,pharmaceutical companies in the world and ...
Other Medicine News:Health News:National Lt. Governors Association Endorses HERO Campaign; 1st National Association of State Elected Officials Supporting Grassroots Designated Driving Program 2Health News:Consumer Group Finds Use of Outdated Data and Other Major Flaws in Economist's Defense of Mandatory Purchase of Private Health Insurance 2Health News:Vaccine Could Cut Bouts With Stomach Flu 2Health News:Ohio Selects Policy Studies Inc. (PSI) to Continue Operating Its New Hire Reporting Program 2Health News:Seal Shield Ships New SILVER SEAL(TM) Washable, Antimicrobial Keyboard 2Health News:GPhA Announces 2008-2009 Executive Committee; Teva North America's Bill Marth Elected as Chairman of the Board 2
(Date:11/24/2009)...irstCall/--NeurocrineBiosciences,Inc.(Nasdaq: NBIX...xecutiveOfficerofNeurocrineBiosciences,willbeprese...ceinNewYork. ,, ThelivepresentationtakesplaceTu...p.m.PacificTime(PT).Thepresentationwillbesimultane...t http://www.neurocrine.com . ,, Ifyouareunable...
(Date:11/24/2009)...e-FirstCall/--ZimmerHoldings,Inc.(NYSE: ZMH ;SIX:Z...ualPiperJaffrayHealthCareConferenceinNewYork,NewYo...livewebcastofthepresentationcanbeaccessedviaZimmer...r.com .Thewebcastwillbearchivedforreplayfollowingt...din1927andheadquarteredinWarsaw,Indiana,Zimmerdesi...
(Date:11/24/2009)...4/PRNewswire/--VisageImaging®,Inc.,awhollyown...ucingVisage®7,thecompany,snewgenerationdiagno...diologicSocietyofNorthAmerica(RSNA),November29toDe...ersnewlevelsofversatilityandperformancetoradiologi...icians.TheVisage7UniversalViewerisasinglethinclien...
Breaking Medicine Technology:Visage Imaging Introduces Visage(R) 7 for Windows and Mac OS X 2Gerresheimer Sells Technical Plastics Business 12861 1Gerresheimer Sells Technical Plastics Business 12861 2A young brain for an old bee 9076 1A young brain for an old bee 9076 2FDA Panel Urges Ban on Vicodin Percocet 50476 1FDA Panel Urges Ban on Vicodin Percocet 50476 2FDA Panel Urges Ban on Vicodin Percocet 50476 3FDA Panel Urges Ban on Vicodin Percocet 50476 4
...lif., June 4 TorreyPines,Therapeutics, Inc. (Nasd...nical trial to evaluate the analgesic effect of NG...te, tezampanel., The randomized, double-blind, pl...thy volunteers at a single center in the United St...nd,s safety and tolerability and to,assess the tim...
...ports Positive Top-line Results from Second Phase ...) -, PT. RICHMOND, Calif., June 4 Transcept Phar...ny deriving significant new patient,benefits from ...leted all,pivotal and supporting clinical trials t...NDA) for its lead product candidate, Intermezzo(R)...
Other Medicine Technology:TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel 2TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel 3Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008 2Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008 3
...c assist system primarily designed as a permanent ...ering heart failure., ,It is a blood pump that...art to help the ailing hearts pumping function and... ,It can also be used as a bridge to heart trans...
Captia™ Varicella-Zoster Virus IgM
...oster Virus (VZV) IgG Enzyme- linked Immunosorbent...uantitative determination of IgG antibody to VZV i...ed for the determination of immune status. Paired ...strate seroconversion or a significant rise in ant...
Varicella-Zoster Virus IgM
Medicine Products: